8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001558370-25-009308
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading plx-20250613x8k.htm…